Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Sarcoma 189Osteosarcoma 72Sarcoma, Ewing 49Rhabdomyosarcoma 44Melanoma 40Neuroblastoma 35Gastrointestinal Stromal Tumors 34Neoplasms 32Colorectal Neoplasms 29Glioblastoma 28Bone Neoplasms 27Neoplasm Metastasis 26Ovarian Neoplasms 25Breast Neoplasms 25Wilms Tumor 22Gliosarcoma 22Glioma 22Rhabdoid Tumor 21Lymphoma, Non-Hodgkin 21Sarcoma, Kaposi 20Liposarcoma 20Carcinoma, Non-Small-Cell Lung 20Pancreatic Neoplasms 18Neurofibrosarcoma 18Medulloblastoma 18Hepatoblastoma 18Carcinoma, Renal Cell 18Lymphoma 17Thyroid Neoplasms 16Desmoid Tumors 16

Interventions

selinexor 1pazopanib 1Proton Therapy 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disorders of Sex Development × Sarcoma × 90 days × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡